Sandra Levy
ARTICLES BY THIS AUTHOR
- 6/1/2020
Strides receives FDA green light for triamcinolone acetonide
Triamcinolone acetonide ointment, 0.05% had a market value of approximately $15 million, according to IQVIA. - 6/1/2020
Surescripts unveils benefits-based prescription price transparency tool
Surescripts Real-Time Prescription Benefit for Pharmacy service helps pharmacists find cost-effective medication options for patients. - 5/31/2020
NACDS calls on CMS to improve COVID-19 test access for Medicare patients
The National Association of Chain Drug Stores is urging the Centers for Medicare and Medicaid Services to codify reimbursement of pharmacies for COVID-19 tests at the same rate as physicians. - 5/31/2020
Scott Knoer sworn in as APhA’s 13th CEO
Scott Knoer is the new CEO and executive vp of APhA, succeeding Thomas Menighan who is retiring after 11 years. - 5/31/2020
2 Lilly drugs get new indications
The FDA has given the green light for new indication's for Lilly's Cyramz, and Taltz. - 5/31/2020
AAM weighs in on pharmacy supply chain during pandemic and beyond
The Association for Accessible Medicines is highlighting to the Senate Finance Committee the factors that contributed to the resiliency of the generic drug supply chain throughout the COVID-19 crisis. - 5/31/2020
Survey: COVID-19 will change the way local pharmacies operate
A survey from the National Community Pharmacists Association found that 56% of pharmacists anticipate the pandemic will lead to an increased scope of practice. - 5/28/2020
FDA grants emergency approval for Quest Diagnostics's self-collection kit
Quest Diagnostics expects more than a half-million self-collection kits to be available by the end of June. - 5/28/2020
Bartell Drugs’ 'Stock the Shelves' Food Drive to benefit Food Lifeline
During June, Bartell Drugs will be collecting nonperishable food items to support Food Lifeline, an organization that partners with 300 food banks, shelters and meal programs in the 17 counties of Western Washington. - 5/28/2020
Glenmark gets FDA nod for chlorzoxazone
Chlorzoxazone tablets have a market value of roughly $20.9 million for the 12 months ending March 2020, according to IQVIA.
